Stifel lowered the firm’s price target on Nyxoah (NYXH) to $10 from $11 and keeps a Buy rating on the shares. The firm, which updated its model for “some moving parts, still reflects an equity raise in Q3 on the heels of ACCCESS data being reported.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NYXH:
- Nyxoah Leverages First Full U.S. Sales Quarter to Power Triple-Digit 2025 Revenue Growth
- Nyxoah reports Q4 EPS (EUR 0.59) vs. (EUR 0.46) last year
- Nyxoah sees Q1 revenue up 25% vs. Q4
- Is NYXH a Buy, Before Earnings?
- Nyxoah’s BREATHE Study: Post‑Approval Data Push for Genio Could Shape Sleep Apnea Market